Shares of Alembic Pharmaceuticals rose 0.45% on Tuesday after Q1 profit grew, even as operating margins came under pressure. Net profit for the June quarter...
Alembic Pharmaceuticals and Aurobindo Pharma issued voluntary recalls of different products in the US markets because of quality issues and manufacturing deficiencies, according to the...
Alembic Pharmaceuticals has receivedΒ tentative approval from USFDA, for Ticagrelor tablets,90 mg. TheΒ tentatively approvedΒ abbreviated new drug application (ANDA) Ticagrelor Tablets, 90 mgΒ is therapeutically equivalent to the...
Alembic Pharmaceuticals has received tentative approval forΒ Iloperidone tablets, from the US health regulator. The approved tablet is used for treatingΒ schizophrenia in adults and this tentatively...
Alembic Pharmaceuticals hasΒ received Establishment Inspection Report (EIR) from US FDA, after the inspection of its Panelav plant. The inspection by USFDA was carried out at...
Alembic Pharmaceuticals has receivedΒ approval for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules USP, 50 mg and 100 mg,Β from the USFDA . The...
The US health regulator has issued 3 observations to Alembic Pharmaceuticals Ltd, after inspecting its formulation facility in Panelav, Gujarat. In a regulatory filing the...